Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa-Reference-Cited by-同舟云学术

Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa

Published:2017-01-05 Issue:1 Volume:11 Page:e0005163
ISSN:1935-2735
Container-title:PLOS Neglected Tropical Diseases
language:en
Short-container-title:PLoS Negl Trop Dis

Author:

Fischer Peter U.,King Christopher L.,Jacobson Julie A.,Weil Gary J.

Publisher

Public Library of Science (PLoS)

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Reference52 articles.

1. The health and economic benefits of the global programme to eliminate lymphatic filariasis (2000–2014);HC Turner;Infect Dis Poverty,2016

2. Uniting to Combat Neglected Tropical Diseases. The London Declaration. [cited 2016 May 10]. http://unitingtocombatntds.org/resource/london-declaration.

3. Strategies and tools for the control/elimination of lymphatic filariasis;EA Ottesen;Bull World Health Organ,1997

4. Global programme to eliminate lymphatic filariasis: progress report, 2015;Wkly Epidemiol Rec,2016

5. Onchocerciasis and lymphatic filariasis elimination in Africa: it's about time;DS Evans;Lancet,2015

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The long and winding road towards new treatments against lymphatic filariasis and onchocerciasis;Trends in Parasitology;2024-09

2. Triple-drug therapy with ivermectin, diethylcarbamazine and albendazole for the acceleration of lymphatic filariasis elimination in Kenya: Programmatic implementation and results of the first impact assessment;PLOS Neglected Tropical Diseases;2024-07-08

3. How Does the Proportion of Never Treatment Influence the Success of Mass Drug Administration Programs for the Elimination of Lymphatic Filariasis?;Clinical Infectious Diseases;2024-04-25

4. Accelerating Progress Towards the 2030 Neglected Tropical Diseases Targets: How Can Quantitative Modeling Support Programmatic Decisions?;Clinical Infectious Diseases;2024-04-25

5. Onchocerca volvulus microfilariae in the anterior chambers of the eye and ocular adverse events after a single dose of 8 mg moxidectin or 150 µg/kg ivermectin: results of a randomized double-blind Phase 3 trial in the Democratic Republic of the Congo, Ghana and Liberia;Parasites & Vectors;2024-03-15